Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board has determined that the reduction of the 100 percent rating for prostate cancer was proper, and a compensable rating (40%) is granted for residuals of prostate cancer.

The deciding factor: The evidence does not indicate local recurrence or metastasis of the Veteran's prostate cancer, which would have required a 100% rating under Diagnostic Code 7528. The Veteran's residuals of prostate cancer are rated based on voiding dysfunction requiring absorbent materials changed two to four times per day.

Claimed conditions
prostate cancer
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
40%
Decision date
April 18, 2018
Citation
1822918

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1822918.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.